A Preliminary Experience with the Human Homologous Vein Graft for Vascular Access

In a preliminary study, 38 preserved human homologous saphenous vein grafts were used for secondary vascular access in 36 chronic hemodialysis patients. Cumulative one-year patency was 67%. Twelve grafts failed, 10 owing to thrombosis and 2 owing to infection. Overall complication rate, morbidity, and patency were compatible with the other available graft materials. A prospective randomized trial of Varivas graft against PTFE has been instigated